The partnership between Synthgene Bio, BIORON, and Bion2 represents a major step toward global expansion, enhancing access to key resources for mRNA and oligo research and manufacturing in Eastern Europe.
FOR IMMEDIATE RELEASE
Gaithersburg, MD, USA and Römerberg, Germany (February 20, 2025) — Areterna LLC, a subsidiary of Synthgene Bio and pioneer with innovative Nucleic Acid and RNA products, established for the purpose of providing raw materials and services tailored to mRNA and oligonucleotide therapeutics, has entered into a further distribution agreement with Bion2, a specialist and distributor of molecular biological products headquartered in Czech Republic. This partnership aims to enhance accessibility to high-quality, cost-effective raw materials and services for mRNA and oligo research and manufacturing in the Czech Republic, Poland, Hungary, Slovenia, Slovakia, Romania and Bulgaria.
The collaboration between Synthgene Bio, BIORON and Bion2 marks a further significant step towards globalization and access to important resources for mRNA and oligo research and manufacturing in East Europe. This strategic alliance is determined to benefit customers by providing them with enhanced access to vital materials necessary for the advancement of mRNA and oligo-related initiatives.
This agreement marks a pivotal moment in Areterna’s mission to democratize mRNA vaccines and therapeutics, highlighting the company’s dedication to delivering GMP-grade raw materials at competitive prices. Simon Koerpert, Senior Director of Business Development EU at Areterna LLC, emphasized the importance of this partnership, stating, “Through our extension with BIORON and Bion2, we anticipate expanding our presence in the fast-growing markets, and aiming to offer more affordable raw materials to support mRNA therapeutics development.”
About BIORON GmbH:
BIORON is a premium manufacturer and worldwide-acting distributor of molecular biological and diagnostic products with more than 20 years of experience and innovation. Its head office located in South-West Germany. BIORON´s specialization lies in the provision of raw materials which are supplied mainly to manufacturers of diagnostic products such as real-time PCR kits. Expansion is currently taking place in the field of Human DNA production. The company is holding the ISO 13485: 2016 certificate (medical). Due to its international orientation and focus on individual customer needs, the BIORON Team has long-term clients in the US, Europe and in many other countries around the globe.
As exclusive importer and distributor for Europe of Synthgene Bio, with its wide range of mRNA products, BIORON´s expertise lies in the efficient supply of research scientists as well as European-based pharmaceutical industry with selected raw materials and services, if required under GDP conditions.
Media Contact:
Tel: +49 (0)6232 298 450
Email: info@bioron.net
Web: www.bioron.net
About Bion2:
Bion2 is dedicated to delivering high-quality products and precise customer service, to ensure customer satisfaction across Central Europe. Although a young company (founded in the beginning of 2024 by an enthusiastic former researcher from the Technical University in Liberec), has quickly established itself as specialist in the distribution of genomics and transcriptomics products portfolio. The company’s primary focus has been on providing innovative solutions tailored to meet the unique needs of our clients in the genomics field. The cooperation with Synthgene-Bio and BIORON will expand Bion2’s offerings to include Synthgene-Bio mRNA-based products, making them more accessible to customers across the region. This strategic expansion reflects Bion2’s commitment to stay at the forefront of groundbreaking technologies and continuously delivering advanced solutions.
Media Contact:
Tel: +42 (0) 7246 232 34
Email: mackova@bion2.eut
Web: www.bion2.eu
About Areterna LLC:
Areterna LLC (www.areterna.com) was founded in 2023 as a wholly owned subsidiary of Synthgene Biotechnology Co., Ltd. to serve customers in the US and Europe. Synthgene provides materials and services to support mRNA and oligonucleotide manufacturing. Founded in 2018 by a group of passionate nucleic acid chemists, the goal of the company is to debottleneck the raw material supply and develop innovative solutions to support customers in the industry. The company has a robust quality system and ISO9001 certification to support cGMP manufacturing of mRNA raw materials that include NTPs, modified NTPs and cap analogs. For the GMP raw materials, Drug Master Files have been filed with FDA. In addition, Synthgene offers analytical development service and mRNA-related impurity standards and detection kits, LNP screening service, IVT process development and IVT kits for mRNA research. For solid-phase DNA and RNA synthesis, Synthgene offers high quality phosphonamidites to support cGMP oligo manufacturing. With over 200 scientists in R&D and AI-assisted discovery platform, Synthgene will continue to bring new products to the market.
Media Contact:
Tel: 240-406-1859
Email: info4@areterna.com
Web: www.areterna.com